Product Recalls in Missouri

Product recalls affecting Missouri — including food, drugs, consumer products, medical devices, and vehicles distributed to Missouri. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,691 recalls have been distributed to Missouri in the last 12 months.

52,570 total recalls
2,691 in last 12 months

Showing 45414560 of 13,409 recalls

DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-Release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2020· Amneal Pharmaceuticals of New York, LLC

Recalled Item: amneal Metformin Hydrochloride Extended-release Tablets Recalled by Amneal...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets Recalled by Lupin Pharmaceuticals Inc. Due to Product Mix...

The Issue: Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Regular Strength Liquid Antacid Cool Mint Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Liquid Antacid Extra Strength Recalled by Glaxosmithkline Consumer...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· AVKARE Inc.

Recalled Item: Lamotrigine Tablets Recalled by AVKARE Inc. Due to Presence of Foreign...

The Issue: Presence of Foreign Substance consistent with granules from desiccant packs...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Regular Strength Liquid Antacid Cool Mint Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· QuVa Pharma, Inc.

Recalled Item: oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Recalled by...

The Issue: Subpotent drug - Product did not contain drug.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 28, 2020· Glaxosmithkline Consumer Healthcare Holdings

Recalled Item: Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry Recalled by...

The Issue: Labeling: Label lacks warning - Magnesium safety warning is not present on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 27, 2020· Pfizer Inc.

Recalled Item: Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg Recalled by...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 27, 2020· Apotex Inc.

Recalled Item: Metformin Hydrochloride Extended-Release Tablets Recalled by Apotex Inc. Due...

The Issue: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 26, 2020· Aurobindo Pharma USA Inc.

Recalled Item: Olanzapine Tablets Recalled by Aurobindo Pharma USA Inc. Due to Failed...

The Issue: Failed Impurities/ Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund